STUDIES ON THE ACTIVATION OF A SERUM "PROTHROMBIN-CONVERTING FACTOR".
作者信息
Jacox R F
机构信息
Department of Medicine of the University of Rochester School of Medicine and Dentistry, Rochester, New York.
出版信息
J Clin Invest. 1949 May;28(3):492-504. doi: 10.1172/JCI102096.
Abstract
摘要
相似文献
1
STUDIES ON THE ACTIVATION OF A SERUM "PROTHROMBIN-CONVERTING FACTOR".血清“凝血酶原转化因子”激活的研究
J Clin Invest. 1949 May;28(3):492-504. doi: 10.1172/JCI102096.
2
Enhanced prothrombin-converting activity and factor Xa binding of platelets activated by the alternative complement pathway.由替代补体途径激活的血小板的凝血酶原转化活性增强及因子Xa结合能力增强。
Br J Haematol. 1984 Jun;57(2):221-8. doi: 10.1111/j.1365-2141.1984.tb08524.x.
3
Activated protein C inhibits platelet prothrombin-converting activity.活化蛋白C抑制血小板凝血酶原转化活性。
Blood. 1979 Dec;54(6):1272-81.
4
Effect of oral contraceptive use on platelet prothrombin converting (platelet factor 3) activity.口服避孕药对血小板凝血酶原转化（血小板因子3）活性的影响。
Thromb Res. 1979;15(5-6):631-8. doi: 10.1016/0049-3848(79)90173-7.
5
6
7
Vibrio vulnificus secretes a broad-specificity metalloprotease capable of interfering with blood homeostasis through prothrombin activation and fibrinolysis.创伤弧菌分泌一种具有广泛特异性的金属蛋白酶，该酶能够通过凝血酶原激活和纤维蛋白溶解来干扰血液稳态。
J Bacteriol. 2005 Oct;187(20):6909-16. doi: 10.1128/JB.187.20.6909-6916.2005.
8
The control of prothrombin conversion. Kinetic control by mechanisms inherent in two activation pathways.凝血酶原转化的控制。由两条激活途径中固有的机制进行动力学控制。
Biochemistry. 1975 Jun 17;14(12):2636-44. doi: 10.1021/bi00683a012.
9
Platelet procoagulant properties studied with snake venom prothrombin activators.用蛇毒凝血酶原激活剂研究血小板促凝特性。
Thromb Haemost. 1987 Jun 3;57(3):349-55.
10
Effect of membrane fluidity and fatty acid composition on the prothrombin-converting activity of phospholipid vesicles.膜流动性和脂肪酸组成对磷脂囊泡凝血酶原转化活性的影响。
Biochemistry. 1992 Oct 20;31(41):10000-8. doi: 10.1021/bi00156a020.
引用本文的文献
1
The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.血清凝血酶原转化加速因子（SPCA）：其部分纯化及其与血清AC球蛋白相比的特性。
J Clin Invest. 1950 Jul;29(7):881-95. doi: 10.1172/JCI102322.
2
The problem of the lipoid thromboplastins.类脂质凝血致活酶的问题。
Yale J Biol Med. 1950 Jul;22(6):675-87.
3
Congenital factor VII deficiency; a review with a report of a case in an Indian infant.先天性因子VII缺乏症；附一例印度婴儿病例报告的综述
Arch Dis Child. 1956 Aug;31(158):293-7. doi: 10.1136/adc.31.158.293.
4
[Reciprocal effects between the promoting and inhibiting substances of the blood coagulation].[血液凝固促进物质与抑制物质之间的相互作用]
Experientia. 1954 Oct 15;10(10):428-9. doi: 10.1007/BF02318510.
5
[New concepts on the mechanism of blood coagulation].[血液凝固机制的新概念]
Experientia. 1954 Jul 15;10(7):273-81. doi: 10.1007/BF02158735.
6
Physiopathological classification of the haemorrhagic diseases.出血性疾病的生理病理分类
Can Med Assoc J. 1952 Dec;67(6):623-9.
本文引用的文献
1
Plasma Accelerator Factor and Purified Prothrombin Activation.血浆促凝因子与纯化凝血酶原激活
Science. 1947 Jul 11;106(2741):41-2. doi: 10.1126/science.106.2741.41-a.
2
The Function of Ac-Globulin in Blood Clotting.抗凝血球蛋白在血液凝固中的作用。
Science. 1947 Dec 19;106(2764):618-9. doi: 10.1126/science.106.2764.618-a.
3
Prothrombokinase and the Three Stages of Blood Coagulation.凝血酶原激酶与血液凝固的三个阶段。
Science. 1947 Dec 5;106(2762):546-7. doi: 10.1126/science.106.2762.546-a.
4
STUDIES ON BLOOD COAGULATION: A PROTEOLYTIC ENZYME PREPARED FROM CALCIUM AND PLATELET FREE NORMAL HUMAN BLOOD PLASMA.血液凝固研究：一种从不含钙和血小板的正常人血浆中制备的蛋白水解酶。
J Clin Invest. 1942 Sep;21(5):525-31. doi: 10.1172/JCI101329.
Zotero 插件